ZhuZhou QianJin Pharmaceutical Co.,Ltd
Symbole: 600479.SS
SHH
10.91
CNYPrix du marché aujourd'hui
17.9517
Ratio P/E
0.4616
Ratio PEG
4.56B
Cap MRK
- 0.03%
Rendement DIV
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479-SS) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1997.9 | 1731.7 | 1369.7 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | -45.7 | 491.7 | 736.8 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 967 | 983.9 | 921.6 | |||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 534.1 | 599 | 547.8 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 15.4 | 198.9 | 78.1 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 3514.5 | 3513.5 | 2917.3 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 589.9 | 622.8 | 630.2 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 14.1 | 14.1 | 14.1 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 238.3 | 221.8 | 219.6 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 252.3 | 235.9 | 233.7 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 293.3 | -304.1 | -546.1 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 22.7 | 6.6 | 4.1 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 4.2 | 547.3 | 821 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1162.4 | 1108.5 | 1143 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 4676.9 | 4622 | 4060.2 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 647.5 | 780.9 | 511.7 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 78.2 | 79.5 | 88.6 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 70.6 | 72.5 | 35.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 38.5 | 44.8 | 60.3 | |||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 38 | 44.4 | 51.3 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 69.1 | 705.6 | 75.5 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 108.3 | 108.5 | 131.9 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 31.5 | 32.8 | 44.8 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 1650.1 | 1805.7 | 1360.3 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 428.9 | 429.8 | 418.5 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 1142.5 | 970.8 | 930.7 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 280.8 | 275.3 | 298.1 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 537.5 | 540.3 | 503 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 2389.7 | 2216.2 | 2150.4 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 4676.9 | 4622 | 4060.2 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 637.1 | 600.1 | 549.5 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 3026.8 | 2816.3 | 2699.9 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||
Total Investments | 0 | 247.6 | 187.6 | 190.8 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 116.7 | 124.2 | 148.9 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | -1881.2 | -1115.7 | -484 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 395 | 388.3 | 374.7 | ||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 103.7 | 95.6 | 85.9 | ||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -2.8 | -3.6 | 2.7 | ||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 2.8 | 3.6 | -2.7 | ||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -81.7 | 246.9 | 65.8 | ||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -8.7 | -163.7 | 275.9 | ||||||||||||||||||||||
cash-flows.row.inventory | 0 | 62.3 | -51.2 | -52.4 | ||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -132.5 | 465.4 | -160.4 | ||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -2.8 | -3.6 | 2.7 | ||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 26.1 | 2.7 | -40.9 | ||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -44 | -34.4 | -71.9 | ||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0.2 | 30.8 | ||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -402 | -2102 | -1570 | ||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 1031.2 | 2258.4 | 1567.7 | ||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0.1 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 585.3 | 122.1 | -43.3 | ||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -50.7 | -15 | -127.6 | ||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -147.9 | -248.6 | -429.5 | ||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -13.1 | -0.5 | 36.5 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -202 | -264.2 | -520.6 | ||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 826.4 | 591.4 | -78.3 | ||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1928.3 | 1101.9 | 510.5 | ||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1101.9 | 510.5 | 588.8 | ||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 443.1 | 733.5 | 485.6 | ||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -44 | -34.4 | -71.9 | ||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 399.1 | 699 | 413.7 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 3798.5 | 4026.3 | 3663.8 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 2046.7 | 2289.9 | 2032.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 1751.8 | 1736.4 | 1631.6 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -3337.9 | 218.6 | 189.1 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 3337.9 | 1311.7 | 1261.1 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 3337.9 | 3601.5 | 3293.4 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 51.4 | 9.8 | 11.9 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 1.7 | 2.2 | 2.1 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1.5 | 1.6 | -2.8 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -3337.9 | 218.6 | 189.1 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -1.5 | 1.6 | -2.8 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 1.7 | 2.2 | 2.1 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 103.7 | 104.2 | 47.3 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 460.6 | 444.2 | 436.2 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 459.1 | 445.8 | 433.4 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 65.4 | 57.6 | 58.7 | |||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 320.4 | 302.5 | 302.1 |
Questions fréquemment posées
Quel est le total de ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) de l'actif total?
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) Le total des actifs est 4676882466.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.465.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est 1.021.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est 0.073.
Quel est le revenu total de l'entreprise?
Le revenu total est 0.121.
Qu'est-ce que ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est 320405834.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 116705915.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 3337921320.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 0.000.